nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Thrombocytosis—Doxorubicin—muscle cancer	0.00613	0.00613	CcSEcCtD
Linezolid—Pancytopenia—Dactinomycin—muscle cancer	0.00605	0.00605	CcSEcCtD
Linezolid—Oral candidiasis—Doxorubicin—muscle cancer	0.006	0.006	CcSEcCtD
Linezolid—Neutropenia—Dactinomycin—muscle cancer	0.00596	0.00596	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.00593	0.00593	CcSEcCtD
Linezolid—Cardiac failure congestive—Etoposide—muscle cancer	0.00589	0.00589	CcSEcCtD
Linezolid—Pneumonia—Dactinomycin—muscle cancer	0.00572	0.00572	CcSEcCtD
Linezolid—Fungal infection—Methotrexate—muscle cancer	0.0057	0.0057	CcSEcCtD
Linezolid—Skin ulcer—Methotrexate—muscle cancer	0.00566	0.00566	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00563	0.00563	CcSEcCtD
Linezolid—Stomatitis—Dactinomycin—muscle cancer	0.00554	0.00554	CcSEcCtD
Linezolid—Pancytopenia—Vincristine—muscle cancer	0.00541	0.00541	CcSEcCtD
Linezolid—Neutropenia—Vincristine—muscle cancer	0.00533	0.00533	CcSEcCtD
Linezolid—Apnoea—Methotrexate—muscle cancer	0.0052	0.0052	CcSEcCtD
Linezolid—Pneumonia—Vincristine—muscle cancer	0.00511	0.00511	CcSEcCtD
Linezolid—Pharyngitis—Dactinomycin—muscle cancer	0.00506	0.00506	CcSEcCtD
Linezolid—Neuropathy peripheral—Vincristine—muscle cancer	0.00498	0.00498	CcSEcCtD
Linezolid—Stomatitis—Vincristine—muscle cancer	0.00495	0.00495	CcSEcCtD
Linezolid—Fungal infection—Doxorubicin—muscle cancer	0.00494	0.00494	CcSEcCtD
Linezolid—Skin ulcer—Doxorubicin—muscle cancer	0.0049	0.0049	CcSEcCtD
Linezolid—Erythema multiforme—Dactinomycin—muscle cancer	0.00482	0.00482	CcSEcCtD
Linezolid—Cramp muscle—Etoposide—muscle cancer	0.00481	0.00481	CcSEcCtD
Linezolid—Glossitis—Methotrexate—muscle cancer	0.00478	0.00478	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00471	0.00471	CcSEcCtD
Linezolid—Chills—Dactinomycin—muscle cancer	0.00458	0.00458	CcSEcCtD
Linezolid—Hypoaesthesia—Vincristine—muscle cancer	0.00454	0.00454	CcSEcCtD
Linezolid—Sweating increased—Etoposide—muscle cancer	0.00449	0.00449	CcSEcCtD
Linezolid—Erythema—Dactinomycin—muscle cancer	0.00444	0.00444	CcSEcCtD
Linezolid—Vaginal inflammation—Methotrexate—muscle cancer	0.0044	0.0044	CcSEcCtD
Linezolid—Pancytopenia—Etoposide—muscle cancer	0.00438	0.00438	CcSEcCtD
Linezolid—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00434	0.00434	CcSEcCtD
Linezolid—Neutropenia—Etoposide—muscle cancer	0.00431	0.00431	CcSEcCtD
Linezolid—Vaginal infection—Methotrexate—muscle cancer	0.00416	0.00416	CcSEcCtD
Linezolid—Glossitis—Doxorubicin—muscle cancer	0.00414	0.00414	CcSEcCtD
Linezolid—Pneumonia—Etoposide—muscle cancer	0.00414	0.00414	CcSEcCtD
Linezolid—Anaemia—Dactinomycin—muscle cancer	0.0041	0.0041	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00408	0.00408	CcSEcCtD
Linezolid—Renal failure—Etoposide—muscle cancer	0.00404	0.00404	CcSEcCtD
Linezolid—Neuropathy peripheral—Etoposide—muscle cancer	0.00403	0.00403	CcSEcCtD
Linezolid—Stomatitis—Etoposide—muscle cancer	0.00401	0.00401	CcSEcCtD
Linezolid—Urine output increased—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Linezolid—Ecchymosis—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Linezolid—Leukopenia—Dactinomycin—muscle cancer	0.00398	0.00398	CcSEcCtD
Linezolid—Sepsis—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Linezolid—Vaginal inflammation—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Linezolid—Thrombophlebitis—Methotrexate—muscle cancer	0.00369	0.00369	CcSEcCtD
Linezolid—Hypoaesthesia—Etoposide—muscle cancer	0.00367	0.00367	CcSEcCtD
Linezolid—Anaemia—Vincristine—muscle cancer	0.00367	0.00367	CcSEcCtD
Linezolid—Polyuria—Methotrexate—muscle cancer	0.00364	0.00364	CcSEcCtD
Linezolid—Candida infection—Doxorubicin—muscle cancer	0.00364	0.00364	CcSEcCtD
Linezolid—Fluid retention—Doxorubicin—muscle cancer	0.00362	0.00362	CcSEcCtD
Linezolid—Vaginal infection—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Linezolid—Neuropathy—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Linezolid—Vertigo—Vincristine—muscle cancer	0.00357	0.00357	CcSEcCtD
Linezolid—Leukopenia—Vincristine—muscle cancer	0.00355	0.00355	CcSEcCtD
Linezolid—Thrombocytopenia—Dactinomycin—muscle cancer	0.00355	0.00355	CcSEcCtD
Linezolid—Erythema multiforme—Etoposide—muscle cancer	0.00349	0.00349	CcSEcCtD
Linezolid—Anorexia—Dactinomycin—muscle cancer	0.00346	0.00346	CcSEcCtD
Linezolid—Ecchymosis—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Linezolid—Convulsion—Vincristine—muscle cancer	0.00344	0.00344	CcSEcCtD
Linezolid—Hypertension—Vincristine—muscle cancer	0.00343	0.00343	CcSEcCtD
Linezolid—Chills—Etoposide—muscle cancer	0.00331	0.00331	CcSEcCtD
Linezolid—Sepsis—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Linezolid—Anaphylactic shock—Vincristine—muscle cancer	0.00324	0.00324	CcSEcCtD
Linezolid—Phlebitis—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Linezolid—Thrombophlebitis—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Linezolid—Thrombocytopenia—Vincristine—muscle cancer	0.00317	0.00317	CcSEcCtD
Linezolid—Decreased appetite—Dactinomycin—muscle cancer	0.00315	0.00315	CcSEcCtD
Linezolid—Dysgeusia—Etoposide—muscle cancer	0.00315	0.00315	CcSEcCtD
Linezolid—Hyperhidrosis—Vincristine—muscle cancer	0.00313	0.00313	CcSEcCtD
Linezolid—Fatigue—Dactinomycin—muscle cancer	0.00313	0.00313	CcSEcCtD
Linezolid—Pain—Dactinomycin—muscle cancer	0.0031	0.0031	CcSEcCtD
Linezolid—Muscle spasms—Etoposide—muscle cancer	0.00309	0.00309	CcSEcCtD
Linezolid—Anorexia—Vincristine—muscle cancer	0.00309	0.00309	CcSEcCtD
Linezolid—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00305	0.00305	CcSEcCtD
Linezolid—Anaemia—Etoposide—muscle cancer	0.00297	0.00297	CcSEcCtD
Linezolid—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00296	0.00296	CcSEcCtD
Linezolid—Liver function test abnormal—Methotrexate—muscle cancer	0.00295	0.00295	CcSEcCtD
Linezolid—Insomnia—Vincristine—muscle cancer	0.00293	0.00293	CcSEcCtD
Linezolid—Paraesthesia—Vincristine—muscle cancer	0.00291	0.00291	CcSEcCtD
Linezolid—Vertigo—Etoposide—muscle cancer	0.00289	0.00289	CcSEcCtD
Linezolid—Leukopenia—Etoposide—muscle cancer	0.00288	0.00288	CcSEcCtD
Linezolid—Abdominal pain—Dactinomycin—muscle cancer	0.00287	0.00287	CcSEcCtD
Linezolid—Body temperature increased—Dactinomycin—muscle cancer	0.00287	0.00287	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Linezolid—Decreased appetite—Vincristine—muscle cancer	0.00282	0.00282	CcSEcCtD
Linezolid—Cough—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Linezolid—Gastrointestinal disorder—Vincristine—muscle cancer	0.0028	0.0028	CcSEcCtD
Linezolid—Fatigue—Vincristine—muscle cancer	0.00279	0.00279	CcSEcCtD
Linezolid—Convulsion—Etoposide—muscle cancer	0.00279	0.00279	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—muscle cancer	0.00278	0.00278	CcSEcCtD
Linezolid—Hypertension—Etoposide—muscle cancer	0.00278	0.00278	CcSEcCtD
Linezolid—Pain—Vincristine—muscle cancer	0.00277	0.00277	CcSEcCtD
Linezolid—Constipation—Vincristine—muscle cancer	0.00277	0.00277	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00277	0.00277	CcSEcCtD
Linezolid—Eosinophilia—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Linezolid—Pancreatitis—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Linezolid—Gastrointestinal pain—Vincristine—muscle cancer	0.00265	0.00265	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—muscle cancer	0.00262	0.00262	CcSEcCtD
Linezolid—Anaphylactic shock—Etoposide—muscle cancer	0.00262	0.00262	CcSEcCtD
Linezolid—Asthenia—Dactinomycin—muscle cancer	0.0026	0.0026	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—muscle cancer	0.00258	0.00258	CcSEcCtD
Linezolid—Thrombocytopenia—Etoposide—muscle cancer	0.00257	0.00257	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Linezolid—Abdominal pain—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Linezolid—Body temperature increased—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—muscle cancer	0.00256	0.00256	CcSEcCtD
Linezolid—Skin disorder—Etoposide—muscle cancer	0.00255	0.00255	CcSEcCtD
Linezolid—Hyperhidrosis—Etoposide—muscle cancer	0.00254	0.00254	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Linezolid—Anorexia—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Linezolid—Diarrhoea—Dactinomycin—muscle cancer	0.00248	0.00248	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—muscle cancer	0.00248	0.00248	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00244	0.00244	CcSEcCtD
Linezolid—Renal failure—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Linezolid—Stomatitis—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—muscle cancer	0.00236	0.00236	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—muscle cancer	0.00235	0.00235	CcSEcCtD
Linezolid—Dyspnoea—Etoposide—muscle cancer	0.00234	0.00234	CcSEcCtD
Linezolid—Somnolence—Etoposide—muscle cancer	0.00233	0.00233	CcSEcCtD
Linezolid—Asthenia—Vincristine—muscle cancer	0.00232	0.00232	CcSEcCtD
Linezolid—Vomiting—Dactinomycin—muscle cancer	0.0023	0.0023	CcSEcCtD
Linezolid—Rash—Dactinomycin—muscle cancer	0.00229	0.00229	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—muscle cancer	0.00227	0.00227	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Linezolid—Fatigue—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Linezolid—Pain—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Linezolid—Constipation—Etoposide—muscle cancer	0.00224	0.00224	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Linezolid—Diarrhoea—Vincristine—muscle cancer	0.00222	0.00222	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—muscle cancer	0.00216	0.00216	CcSEcCtD
Linezolid—Nausea—Dactinomycin—muscle cancer	0.00215	0.00215	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—muscle cancer	0.00215	0.00215	CcSEcCtD
Linezolid—Dizziness—Vincristine—muscle cancer	0.00214	0.00214	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—muscle cancer	0.00209	0.00209	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Linezolid—Urticaria—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Linezolid—Vomiting—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Linezolid—Rash—Vincristine—muscle cancer	0.00204	0.00204	CcSEcCtD
Linezolid—Dermatitis—Vincristine—muscle cancer	0.00204	0.00204	CcSEcCtD
Linezolid—Headache—Vincristine—muscle cancer	0.00203	0.00203	CcSEcCtD
Linezolid—Chills—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Linezolid—Erythema—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Linezolid—Nausea—Vincristine—muscle cancer	0.00192	0.00192	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Linezolid—Asthenia—Etoposide—muscle cancer	0.00188	0.00188	CcSEcCtD
Linezolid—Pruritus—Etoposide—muscle cancer	0.00186	0.00186	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Linezolid—Diarrhoea—Etoposide—muscle cancer	0.00179	0.00179	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Linezolid—Anaemia—Methotrexate—muscle cancer	0.00178	0.00178	CcSEcCtD
Linezolid—Dizziness—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Linezolid—Vertigo—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Linezolid—Chills—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Linezolid—Cough—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Linezolid—Convulsion—Methotrexate—muscle cancer	0.00167	0.00167	CcSEcCtD
Linezolid—Vomiting—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Linezolid—Erythema—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Linezolid—Rash—Etoposide—muscle cancer	0.00165	0.00165	CcSEcCtD
Linezolid—Dermatitis—Etoposide—muscle cancer	0.00165	0.00165	CcSEcCtD
Linezolid—Headache—Etoposide—muscle cancer	0.00164	0.00164	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Linezolid—Nausea—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Linezolid—Anorexia—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Linezolid—Cough—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Linezolid—Insomnia—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Linezolid—Paraesthesia—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Linezolid—Somnolence—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00136	0.00136	CcSEcCtD
Linezolid—Fatigue—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Linezolid—Pain—Methotrexate—muscle cancer	0.00134	0.00134	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Linezolid—Gastrointestinal pain—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Linezolid—Urticaria—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Linezolid—Pain—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Constipation—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Linezolid—Asthenia—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Linezolid—Pruritus—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Linezolid—Dizziness—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Linezolid—Vomiting—Methotrexate—muscle cancer	0.000999	0.000999	CcSEcCtD
Linezolid—Rash—Methotrexate—muscle cancer	0.000991	0.000991	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—muscle cancer	0.00099	0.00099	CcSEcCtD
Linezolid—Headache—Methotrexate—muscle cancer	0.000984	0.000984	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—muscle cancer	0.000976	0.000976	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—muscle cancer	0.000963	0.000963	CcSEcCtD
Linezolid—Nausea—Methotrexate—muscle cancer	0.000933	0.000933	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—muscle cancer	0.000931	0.000931	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—muscle cancer	0.0009	0.0009	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—muscle cancer	0.000865	0.000865	CcSEcCtD
Linezolid—Rash—Doxorubicin—muscle cancer	0.000858	0.000858	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—muscle cancer	0.000857	0.000857	CcSEcCtD
Linezolid—Headache—Doxorubicin—muscle cancer	0.000852	0.000852	CcSEcCtD
Linezolid—Nausea—Doxorubicin—muscle cancer	0.000808	0.000808	CcSEcCtD
